Head and Neck Mucosal Squamous Cell Carcinoma

Head and Neck Mucosal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 160
Recruiting: 78
Ph III recruiting: 9
Growth YoY: +30%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (60)

clinicaltrialsPublishedShowing 201–207 of 207 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00095641	S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer	withdrawn	Phase 2	0	SWOG Cancer Research NetworkNETWORK	0	Nov 8, 2013	clinicaltrials
NCT01596868	GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China	completed	Phase 2	60	Air Force Military Medical University, ChinaOTHER	1	Oct 30, 2013	clinicaltrials